Core Viewpoint - Meihua Medical's stock price has experienced a slight decline, and the company has made significant adjustments to its stock incentive plans, reflecting changes in shareholder structure and performance metrics [1][2][4]. Shareholder Changes - As of May 9, 2025, the number of shareholders in Meihua Medical decreased by 525, representing a reduction of 4.85%. The average number of shares held per shareholder increased from 37,600 to 39,500, with an average holding value of 1,000,500 yuan [1][4]. Stock Incentive Plan - Meihua Medical announced the results of the first vesting period for its 2024 stock incentive plan, with 1,236,792 shares (0.30% of total shares) becoming tradable on May 16, 2025. The vesting was impacted by performance metrics, resulting in a 80% vesting ratio and the cancellation of 309,198 shares due to unfulfilled targets [1][4]. - The company held its 18th board meeting, approving the adjustment of the 2025 stock incentive plan, reducing the number of initial grantees from 304 to 303 while maintaining the total number of shares at 4,012,900. The grant date is set for May 23, 2025, with a grant price of 13.39 yuan per share [2][5]. Legal and Financial Advisory - The independent financial advisor confirmed that the adjustments and grants under the 2025 stock incentive plan comply with relevant laws and regulations, ensuring that all necessary approvals were obtained [3][5].
每周股票复盘：美好医疗（301363）股东户数减少，限制性股票激励计划进展